Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04462081 · ClinicalTrials.gov registry record
Non Alcoholic Fatty Liver Disease and Coronary Heart Disease in Type 2 Diabetes Patients
A clinical trial, sponsored by University of California, San Diego.
- Completed
- Registry status
- 100
- Enrollment target
NCT04462081 is a clinical trial that has completed, run by University of California, San Diego. The registered enrollment target is 100 participants.
The verdict
NCT04462081 has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
To assess the feasibility in diabetics in a primary care setting of screening for NAFLD and advanced fibrosis, by using non-invasive magnetic resonance imaging (MRI) to estimate the hepatic proton density fat fraction (MRI-PDFF) and magnetic resonance elastography (MRE) to estimate hepatic stiffness.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2013-01 |
| Est. Completion | 2015-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04462081
The ClinicalTrials.gov registry entry for NCT04462081 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04462081 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04462081 about?
NCT04462081 is a clinical study titled "Non Alcoholic Fatty Liver Disease and Coronary Heart Disease in Type 2 Diabetes Patients". To assess the feasibility in diabetics in a primary care setting of screening for NAFLD and advanced fibrosis, by using non-invasive magnetic resonance imaging (MRI) to estimate the hepatic proton density fat fraction (MRI-PDFF) and magnetic resonance elastography (MRE) to estimate hepatic stiffness...
What is the current status of trial NCT04462081?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2013-01. Estimated completion is 2015-01.
Who is sponsoring clinical trial NCT04462081?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.